000			01559 a2200433 4500
005			20250512134503.0
264		0	_c19721030
008			197210s 0 0 eng d
022			_a0012-6667
024	7		_a10.2165/00003495-197101050-00002 _2doi
040			_aNLM _beng _cNLM
245	0	0	_aRifampicin: a review. _h[electronic resource]
260			_bDrugs _c1971
300			_a354-98 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAbnormalities, Drug-Induced
650	0	4	_aAnti-Bacterial Agents
650	0	4	_aAnti-Infective Agents _xpharmacology
650	0	4	_aBacterial Infections _xdrug therapy
650	0	4	_aChemical and Drug Induced Liver Injury
650	0	4	_aDrug Interactions
650	0	4	_aDrug Resistance, Microbial
650	0	4	_aEndocarditis, Bacterial _xdrug therapy
650	0	4	_aGonorrhea _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIntestinal Absorption _xdrug effects
650	0	4	_aLeprosy _xdrug therapy
650	0	4	_aMeningococcal Infections _xdrug therapy
650	0	4	_aMycobacterium
650	0	4	_aRespiratory Tract Infections _xdrug therapy
650	0	4	_aRifampin _xadministration & dosage
650	0	4	_aThrombocytosis _xchemically induced
650	0	4	_aTuberculosis _xdrug therapy
650	0	4	_aTuberculosis, Pulmonary _xdrug therapy
650	0	4	_aUrologic Diseases _xdrug therapy
650	0	4	_aViruses _xdrug effects
773	0		_tDrugs _gvol. 1 _gno. 5 _gp. 354-98
856	4	0	_uhttps://doi.org/10.2165/00003495-197101050-00002 _zAvailable from publisher's website
999			_c4951931 _d4951931